Organ distribution and biliary excretion of intravenously injected insulin-like growth factor-I in suckling rats

Wuyi Kong, Otakar Koldovsky, Mats Lake, Gary G. Anderson, Anthony F Philipps

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

The organ distribution of intravenously injected 125I-IGF-I at a dose of 2-4 x 106 cpm or 5-10 ng/animal was studied in 10-to 12-day-old Sprague-Dawley rats at 5 and 30 min after injection. Results of the study suggest that, although the main portion of intravenous IGF-I remains in the circulation, significant amounts are also found in the carcass, liver and kidney. Blood radioactivity fell by 50% 30 min after injection, but concentrations in the carcass, liver, kidney and skin either remained stable or increased. Gel chromatography demonstrated that significant portions of radioactivity recovered from serum, liver and kidney coeluted in a position identical to the injected IGF-I. In addition, the extracted peptide bound competitively to a membrane IGF-I receptor preparation. Studies performed on liver and kidney from these animals 5 min after injection showed that on a per gram wet weight basis, these organs contained equivalent amounts of 125I-IGF-I. However, although by 30 min, 65% of the intact labelled IGF-I has been removed from the liver, the amount remaining in kidney tissue was equal to that noted 5 min after injection. Bile was collected over a 2-hour period and contained approximately 2% of the injected radioactivity and a significant portion (30%) of this radioactivity coeluted with native IGF-I. This material also bound competitively in a radioreceptor assay, suggesting 'intactness' of this peptide. From this study, we conclude that (a) IGF-I, when administered intravenously, remains for at least 30 min in a receptor-active form in blood and several organs; (b) IGF-I derived from the circulation is cleared from the liver more quickly than from the kidney of suckling rats, and (c) that IGF-I is transferred from blood to bile.

Original languageEnglish (US)
Pages (from-to)239-250
Number of pages12
JournalBiology of the Neonate
Volume71
Issue number4
StatePublished - 1997
Externally publishedYes

Fingerprint

Insulin-Like Growth Factor I
Kidney
Radioactivity
Liver
Injections
Bile
Hepatobiliary Elimination
Radioligand Assay
IGF Type 1 Receptor
Peptides
Organ Size
Gel Chromatography
Sprague Dawley Rats
Skin
Membranes
Serum

Keywords

  • Bile
  • Gut development
  • Insulin-like growth factors
  • Suckling rats

ASJC Scopus subject areas

  • Developmental Biology
  • Pediatrics, Perinatology, and Child Health

Cite this

Organ distribution and biliary excretion of intravenously injected insulin-like growth factor-I in suckling rats. / Kong, Wuyi; Koldovsky, Otakar; Lake, Mats; Anderson, Gary G.; Philipps, Anthony F.

In: Biology of the Neonate, Vol. 71, No. 4, 1997, p. 239-250.

Research output: Contribution to journalArticle

Kong, Wuyi ; Koldovsky, Otakar ; Lake, Mats ; Anderson, Gary G. ; Philipps, Anthony F. / Organ distribution and biliary excretion of intravenously injected insulin-like growth factor-I in suckling rats. In: Biology of the Neonate. 1997 ; Vol. 71, No. 4. pp. 239-250.
@article{c2e77d6ee34e4d8fbbbe93df38737b92,
title = "Organ distribution and biliary excretion of intravenously injected insulin-like growth factor-I in suckling rats",
abstract = "The organ distribution of intravenously injected 125I-IGF-I at a dose of 2-4 x 106 cpm or 5-10 ng/animal was studied in 10-to 12-day-old Sprague-Dawley rats at 5 and 30 min after injection. Results of the study suggest that, although the main portion of intravenous IGF-I remains in the circulation, significant amounts are also found in the carcass, liver and kidney. Blood radioactivity fell by 50{\%} 30 min after injection, but concentrations in the carcass, liver, kidney and skin either remained stable or increased. Gel chromatography demonstrated that significant portions of radioactivity recovered from serum, liver and kidney coeluted in a position identical to the injected IGF-I. In addition, the extracted peptide bound competitively to a membrane IGF-I receptor preparation. Studies performed on liver and kidney from these animals 5 min after injection showed that on a per gram wet weight basis, these organs contained equivalent amounts of 125I-IGF-I. However, although by 30 min, 65{\%} of the intact labelled IGF-I has been removed from the liver, the amount remaining in kidney tissue was equal to that noted 5 min after injection. Bile was collected over a 2-hour period and contained approximately 2{\%} of the injected radioactivity and a significant portion (30{\%}) of this radioactivity coeluted with native IGF-I. This material also bound competitively in a radioreceptor assay, suggesting 'intactness' of this peptide. From this study, we conclude that (a) IGF-I, when administered intravenously, remains for at least 30 min in a receptor-active form in blood and several organs; (b) IGF-I derived from the circulation is cleared from the liver more quickly than from the kidney of suckling rats, and (c) that IGF-I is transferred from blood to bile.",
keywords = "Bile, Gut development, Insulin-like growth factors, Suckling rats",
author = "Wuyi Kong and Otakar Koldovsky and Mats Lake and Anderson, {Gary G.} and Philipps, {Anthony F}",
year = "1997",
language = "English (US)",
volume = "71",
pages = "239--250",
journal = "Neonatology",
issn = "1661-7800",
publisher = "S. Karger AG",
number = "4",

}

TY - JOUR

T1 - Organ distribution and biliary excretion of intravenously injected insulin-like growth factor-I in suckling rats

AU - Kong, Wuyi

AU - Koldovsky, Otakar

AU - Lake, Mats

AU - Anderson, Gary G.

AU - Philipps, Anthony F

PY - 1997

Y1 - 1997

N2 - The organ distribution of intravenously injected 125I-IGF-I at a dose of 2-4 x 106 cpm or 5-10 ng/animal was studied in 10-to 12-day-old Sprague-Dawley rats at 5 and 30 min after injection. Results of the study suggest that, although the main portion of intravenous IGF-I remains in the circulation, significant amounts are also found in the carcass, liver and kidney. Blood radioactivity fell by 50% 30 min after injection, but concentrations in the carcass, liver, kidney and skin either remained stable or increased. Gel chromatography demonstrated that significant portions of radioactivity recovered from serum, liver and kidney coeluted in a position identical to the injected IGF-I. In addition, the extracted peptide bound competitively to a membrane IGF-I receptor preparation. Studies performed on liver and kidney from these animals 5 min after injection showed that on a per gram wet weight basis, these organs contained equivalent amounts of 125I-IGF-I. However, although by 30 min, 65% of the intact labelled IGF-I has been removed from the liver, the amount remaining in kidney tissue was equal to that noted 5 min after injection. Bile was collected over a 2-hour period and contained approximately 2% of the injected radioactivity and a significant portion (30%) of this radioactivity coeluted with native IGF-I. This material also bound competitively in a radioreceptor assay, suggesting 'intactness' of this peptide. From this study, we conclude that (a) IGF-I, when administered intravenously, remains for at least 30 min in a receptor-active form in blood and several organs; (b) IGF-I derived from the circulation is cleared from the liver more quickly than from the kidney of suckling rats, and (c) that IGF-I is transferred from blood to bile.

AB - The organ distribution of intravenously injected 125I-IGF-I at a dose of 2-4 x 106 cpm or 5-10 ng/animal was studied in 10-to 12-day-old Sprague-Dawley rats at 5 and 30 min after injection. Results of the study suggest that, although the main portion of intravenous IGF-I remains in the circulation, significant amounts are also found in the carcass, liver and kidney. Blood radioactivity fell by 50% 30 min after injection, but concentrations in the carcass, liver, kidney and skin either remained stable or increased. Gel chromatography demonstrated that significant portions of radioactivity recovered from serum, liver and kidney coeluted in a position identical to the injected IGF-I. In addition, the extracted peptide bound competitively to a membrane IGF-I receptor preparation. Studies performed on liver and kidney from these animals 5 min after injection showed that on a per gram wet weight basis, these organs contained equivalent amounts of 125I-IGF-I. However, although by 30 min, 65% of the intact labelled IGF-I has been removed from the liver, the amount remaining in kidney tissue was equal to that noted 5 min after injection. Bile was collected over a 2-hour period and contained approximately 2% of the injected radioactivity and a significant portion (30%) of this radioactivity coeluted with native IGF-I. This material also bound competitively in a radioreceptor assay, suggesting 'intactness' of this peptide. From this study, we conclude that (a) IGF-I, when administered intravenously, remains for at least 30 min in a receptor-active form in blood and several organs; (b) IGF-I derived from the circulation is cleared from the liver more quickly than from the kidney of suckling rats, and (c) that IGF-I is transferred from blood to bile.

KW - Bile

KW - Gut development

KW - Insulin-like growth factors

KW - Suckling rats

UR - http://www.scopus.com/inward/record.url?scp=0030961956&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030961956&partnerID=8YFLogxK

M3 - Article

C2 - 9129793

AN - SCOPUS:0030961956

VL - 71

SP - 239

EP - 250

JO - Neonatology

JF - Neonatology

SN - 1661-7800

IS - 4

ER -